Abstract

Hypocalcemia is a recognized complication following thyroid surgery. Variability in the definition of hypocalcemia and different opinions on its management can lead to unnecessary patient morbidity and longer hospital stays as a result of inappropriate or untimely treatment. Therefore, we developed a management guideline for the recognition and treatment of post-thyroidectomy hypocalcemia, and we conducted a retrospective study to assess its impact on length of stay (LOS). Between April 1, 2007, and March 31, 2009, 29 adults had undergone a total or completion thyroidectomy at our large district general hospital. Of this group, postoperative hypocalcemia (defined as a serum calcium level of <2.00 mmol/L) developed in 13 patients (44.8%) during the first 3 postoperative days.
Our guideline went into effect on July 1, 2009, and 
Introduction
Hypocalcemia is a recognized complication following thyroid surgery. Its reported incidence has varied greatly, ranging from 5 to 75%. [1] [2] [3] [4] [5] [6] [7] [8] This wide range can be attributed to inconsistencies in the criteria for defining hypocalcemia among different laboratories and populations. The incidence is also influenced by the underlying pathology and the type of surgical procedure performed; for example, the incidence is higher among patients who undergo surgery for thyrotoxicosis 9, 10 and for those who undergo a bilateral procedure 10 than it is for patients who undergo other types of thyroid surgery.
Hypocalcemia can be temporary or permanent. The former is more common, and it tends to resolve a few days or weeks after surgery. Causes of temporary postoperative hypocalcemia are devascularization of the glands and "hungry bone syndrome, " which occurs as a result of the reversal of thyrotoxic osteodystrophy. 11 Hypocalcemia is generally regarded as permanent when it persists for 6 months after surgery. 4 In many cases, the permanent form occurs as a result of the inadvertent removal of the parathyroid glands. 12 Some cases of hypocalcemia are asymptomatic, others are mildly symptomatic, and some lead to significant cardiac and neurologic complications. Therefore, it is important to stratify risk in patients who develop hypocalcemia and to identify those who require management with calcium and/or vitamin D supplementation.
Since differences in the definition of hypocalcemia and the subjectivity involved in the initiation of treatment have fostered a wide variation in management practices, even within a single center, the resulting uncertainty and confusion among patients and hospital staff can lead to delayed discharge after thyroid surgery. Therefore, it is important from a clinical governance perspective that each Post-thyroidectomy hyPocalcemia: imPact on length of stay center obtain data on the local incidence of postoperative hypocalcemia and establish a locally agreed-upon guideline for its management. A standardized approach to management would be expected to improve patient care, facilitate the process of obtaining informed consent, and lead to a reduction in the length of hospital stay. 1, 13 Until June 2009, there was no formal guidance on the management of postoperative hypocalcemia at our institution. To remedy this, we conducted a study to identify the incidence of hypocalcemia after total and completion thyroid surgery, to determine the impact of hypocalcemia on length of stay (LOS), to review the existing management of postoperative hypocalcemia, and to review these data after the implementation of a standardized postoperative management guideline. We also endeavored to determine if we could predict normocalcemia on postoperative day 1.
Patients and methods
We retrospectively reviewed our hospital's coding system to identify all patients who had undergone a total or completion thyroidectomy from April 1, 2007, to March 31, 2009, and again from July 1, 2009, to June 30, 2010. This list was cross-checked with the operating theater logbook for completeness. Patients who had undergone a thyroid lobectomy without completion surgery were not included in this study because the rate of hypocalcemia in these patients is low.
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For the first phase of the study, we identified 29 adults who had undergone a total or completion thyroidectomy. These patients had been treated before the implementation of our standardized postoperative management guideline.
For the second phase of the study, which covered the period after implementation of the guidelines in July 2009, we identified 18 thyroidectomy patients. There was no statistically significant difference in age between the two groups.
In addition to demographic information, we reviewed patient records for the specific type of operative procedure that was performed, patients' serum calcium levels, LOS, early detection of postoperative normocalcemia, the type of treatment, and follow-up. Hypocalcemia was defined as a serum calcium level of <2.00 mmol/L.
Our standardized management guideline was based on clinical experience and a review of calcium levels in the first group (figure 1). Consensus was achieved with all departments concerned.
Data analysis was performed using descriptive statistics, the chi-square test was used for categorical data, and the Student t test and the Wilcoxon rank sum test were used for continuous data. An analysis of serum calcium levels was performed to determine if early postoperative serum calcium levels or the rate of decline in serum calcium levels could be used to identify patients who would remain normocalcemic and who could therefore be discharged safely on postoperative day 1.
Results
Type of surgery.
Of the 29 cases in the preguideline phase, 18 were total thyroidectomies and 11 were completion thyroidectomies. In the postguideline phase, the corresponding figures were 16 and 2 (table 1) .
Incidence of hypocalcemia. In the first group, postoperative hypocalcemia developed during the first 3 days in 13 patients (44.8%). Symptoms developed in 5 of these patients (table 1) .
In the second group, postoperative hypocalcemia developed in 7 patients (38.9%). Only 2 of these patients developed symptoms (table 1). The postoperative management guideline was actually followed in 5 of these 7 cases (71.4%).
The difference between the rates of hypocalcemia in the two groups was not statistically significant.
Length of stay. The mean LOS for all patients was 4.2 days in the first group and 3.1 days in the second group (p > 0.05). In the first group, the mean LOS was 2.0 days for those who did not develop hypocalcemia and 7.0 days for those who did-a statistically significant difference (p < 0.001). After guideline implementation, the corresponding figures were 2.7 and 3.7-again, a significant difference (p = 0.07).
While the LOS in the second group was roughly half that of the first group, the difference did not reach statistical significance. Nevertheless, we believe the reason probably reflects the relatively small number of patients rather than any lack of guideline efficacy.
Early identification of normocalcemia. An analysis of serum calcium levels in the first group demonstrated that the most rapid decline in these levels occurred during the initial 4 to 6 hours postoperatively. The predictive value of a single 4-to 6-hour corrected serum calcium measurement in identifying patients remaining normocalcemic during the first 3 postoperative days is shown in table 2. The maximum positive predictive value obtained using this criterion was 85.7% (95% CI: 42.0 to 99.2) for an absolute serum calcium level of ≥2.16 mmol/L. The combination of an absolute serum calcium level at 4 to 6 hours and the change in level from the preoperative value was not an accurate predictor of normocalcemia ( figure 2) .
Hypocalcemia management. Before guideline implementation, 7 of the 29 patients (24.1%) received intravenous (IV) calcium gluconate after surgery. Of these, 4 patients experienced symptoms of hypocalcemia; the 3 asymptomatic patients all had a corrected serum calcium level of ≥1.92 mmol/L. The reason for intravenous calcium supplementation in these patients was unclear. A total of 11 patients ENT-Ear, Nose & Throat Journal  July 2015 (37.9%) were treated with oral calcium and/or vitamin D supplementation after surgery. There was no standard regimen for either calcium or vitamin D supplementation, and nine different calcium regimens and five different vitamin D regimens had been prescribed. The supplemental calcium dosages ranged from 1,500 to 6,000 mg/day, and the vitamin D dosages ranged from 0.25 to 2 μg/day. None of these variations was explained by the need for dosage adjustment based on a patient's response.
After guideline implementation, 5 of the 7 hypocalcemic patients (71.4%) were correctly started on oral supplements. All 5 patients received the same treatment regimen. Intravenous calcium was indicated in 3 patients, and it was appropriately administered in all 3.
Follow-up. During follow-up, 3 patients in the first group remained eucalcemic without the need for any supplements at 6 months postoperatively, while 2 others continued to require supplements. This resulted in a permanent hypocalcemia rate of 6.9% (2/29). There were no cases of permanent hypocalcemia in the second group.
Discussion
Our study found that the overall incidence of post-thyroidectomy hypocalcemia in our unit was 42.6% (20/47). While that figure might seem high, reports in the literature put the incidence as high as 75%. [1] [2] [3] [4] [5] [6] [7] [8] As mentioned, the wide variations in hypocalcemia rates are almost certainly attributable to differences in the definition of hypocalcemia. Laboratories have their own reference ranges and preferred times of measurement. In addition, some studies included only those patients who were symptomatic, while others based the incidence solely on serum calcium levels. We believe it is likely that reporting bias also played a role, as the authors of some studies with higher rates might not have wished to publish their findings.
The rate of symptomatic hypocalcemia in our study was 14.9% (7/47), which is in line with rates of about 20% reported by others. 12, 14 Our rate of permanent hypocalcemia was 4.3% (2/47), which is also in line with reported rates of between 0% 6 and 6%.
success has been borne out in our study's findings. Our findings also illustrate the significant impact that hypocalcemia has on LOS after thyroid surgery. Before our guideline was implemented, patients who developed hypocalcemia had an average LOS of 7.0 days; after guideline implementation, the mean LOS among those with hypocalcemia was reduced by almost half to 3.7 days. While the difference was not statistically significant, we believe it is clinically significant.
A prolonged LOS is associated with increased morbidity from hospital-acquired infections and deep vein thrombosis. Obviously, it also has substantial implications for healthcare costs and the availability of hospital beds, particularly in the U.K. 15 While there is limited evidence available as to whether early treatment translates to a shorter hospital stay, this would appear to be likely.
The ability to discharge patients on the basis of an early prediction of postoperative hypocalcemia would obviously be contingent on the positive predictive value being high. We based our predictions on a combination of serum calcium levels at 4 to 6 hours after surgery and the decline in levels from the preoperative baseline. However, the maximum positive predictive value that we were able to achieve was 85.7%, which is inadequate for determining the likelihood of postoperative hypocalcemia, since almost 15% of patients would be sent home only to develop hypocalcemia later. Published studies using the same criteria have yielded similar results, 4 so this method is not regarded as sensitive or specific enough for routine use.
Meanwhile, the measurement of parathyroid hormone (PTH) levels has shown some promise in facilitating the early identification of hypocalcemia. Studies have suggested that the sensitivity of a PTH assay is in the range of 97 to 100%, even when it is performed as early as 1 hour postoperatively. 14, [16] [17] [18] [19] The use of PTH levels requires further investigation, and our group is analyzing these data to assess its use. Certainly, the cost of any additional laboratory investigation would have to be balanced against the reductions in LOS and patient morbidity.
In conclusion, we have shown that without clinical guidelines, the management of postoperative hypocalcemia in our of hypocalcemia has allowed us to provide more accurate information to our patients about this postoperative complication. Informed consent is an important aspect of surgical care, and while we have demonstrated that most patients are informed about potential hypocalcemia, it is likely that the incidence of temporary hypocalcemia has been understated in the past. Also, we are now able to reassure our patients that the risk of permanent hypocalcemia is very low, even if they require supplementation in the initial postoperative period. Finally, our findings allowed us to review the various strategies that were used for managing postoperative hypocalcemia at our hospital and confirmed that there were considerable variations in them. For example, it appeared that IV calcium gluconate was administered to some patients without any clear indication for it.
The use of IV calcium gluconate in patients who are asymptomatic might result in unnecessary risk, with potential side effects including hypotension and arrhythmias. Also, the wide variation in the prescription of oral calcium and vitamin D supplements did not appear to be related to any particular medical indication but instead to the preference of the surgeon or prescriber. Moreover, it is interesting that not only the type of supplementation varied, but also the total doses of calcium and vitamin D varied considerably (4-and 16-fold, respectively).
The guideline that we produced has helped us to standardize postoperative hypocalcemia management, and its Post-thyroidectomy hyPocalcemia:
imPact on length of stay hospital was variable. We believe that our findings probably mirror those of other centers. The implementation of a simple flowchart guideline has helped to standardize the management of postoperative hypocalcemia and reduce LOS in our unit. We believe that our guideline has improved patient care and may be adapted for use in other units.
